Advertisement
Screener

PAVmed Inc. (PAVM) Deferred Federal Income Tax Expense (Benefit)

PAVmed Inc. Deferred Federal Income Tax Expense (Benefit)

PAVmed Inc. (PAVM) reported Deferred Federal Income Tax Expense (Benefit) of $5.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-27

  • PAVmed Inc. deferred federal income tax expense (benefit) for fiscal 2025 was $5.71M.
  • PAVmed Inc. deferred federal income tax expense (benefit) for fiscal 2024 was -$6.96M.
  • PAVmed Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$16.79M.
  • PAVmed Inc. deferred federal income tax expense (benefit) for fiscal 2022 was -$24.27M.
Period endDeferred Federal Income Tax Expense (Benefit) 12 monthDeferred Federal Income Tax Expense (Benefit) 12 month as first filed
2025-12-31$5.71M
10-K · filed 2026-03-27
2024-12-31-$6.96M
10-K · filed 2026-03-27
2023-12-31-$16.79M
10-K · filed 2025-03-24
2022-12-31-$24.27M
10-K · filed 2024-03-25
2021-12-31-$9.53M
10-K · filed 2023-03-14
2020-12-31-$4.57M
10-K · filed 2022-04-06
2019-12-31-$3.34M
10-K · filed 2021-03-15
-$3.34M
10-K · filed 2020-04-14
2018-12-31-$2.99M
10-K · filed 2020-04-14
2017-12-31-$105.09K
10-K · filed 2019-04-01
2016-12-31-$1.95M
10-K · filed 2018-03-14
2015-12-31-$593.74K
10-K · filed 2017-02-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
InspireMD, Inc. (NSPR)$0.033B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
NEPHROS INC (NEPH)United States$0.046B23.02
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14